X9 Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $8.57M

  • Investors
  • 3

X9 General Information

Description

Developer of robotic medical imaging and procedural assistance technology intended for minimally invasive diagnostics and interventions. The company's platform integrates real-time AI-guided ultrasound imaging with robotic precision and a single-handed interface, enabling healthcare providers across hospital and outpatient settings to perform delicate procedures with increased accuracy, reduced variability, automated data capture while minimizing training requirements and administrative burden.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10 Research Parkway
  • Suite 350
  • Wallingford, CT 06492
  • United States
+1 (650)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 10 Research Parkway
  • Suite 350
  • Wallingford, CT 06492
  • United States
+1 (650)

X9 Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

X9 Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 24-Nov-2025 $8.57M Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 01-Dec-2022 Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view X9’s complete valuation and funding history, request access »

X9 Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view X9’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

X9 Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

X9 Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
M&L Group Venture Capital Minority
Unorthodox Ventures Venture Capital Minority
ExploraMed Accelerator/Incubator
To view X9’s complete investors history, request access »

X9 FAQs

  • When was X9 founded?

    X9 was founded in 2022.

  • Where is X9 headquartered?

    X9 is headquartered in Wallingford, CT.

  • What is the size of X9?

    X9 has 7 total employees.

  • What industry is X9 in?

    X9’s primary industry is Diagnostic Equipment.

  • Is X9 a private or public company?

    X9 is a Private company.

  • What is the current valuation of X9?

    The current valuation of X9 is .

  • What is X9’s current revenue?

    The current revenue for X9 is .

  • How much funding has X9 raised over time?

    X9 has raised $13.7M.

  • Who are X9’s investors?

    M&L Group, Unorthodox Ventures, and ExploraMed have invested in X9.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process